Search

everythinglearnresearchcommunity

for

Search:↓

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Topical treatments led to hair regrowth in a man with linear morphea.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

COPD flare-ups worsen life quality and increase hospital visits and costs.

TNF-alpha inhibitors can cause various immune-related skin issues.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.

Hair follicle stem cells might help treat traumatic brain injury.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

BMS-470539 reduces skin fibrosis and inflammation.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

People with alopecia areata often have thyroid autoimmunity.

Pantethine may boost the immune system's ability to fight sarcoma.

Boxer dogs may have a genetic skin condition that worsens seasonally and can be treated with certain medications.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.